Serum METRNL Concentration in Type 2 Diabetes

Comparison of Serum METRNL Concentration Between Type 2 Diabetes and Normal Glucose Tolerance

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03194100

Enrollment

125

Registered

2017-06-21

Start date

2014-01-01

Completion date

2016-11-30

Last updated

2017-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

The investigators measured serum METRNL levels in newly diagnosed patients with type 2 diabetes (T2DM) compared with normal glucose tolerance or prediabetes and explored the correlations between its serum levels and various metabolic parameters

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Subjects who have not been diagnosed diabetes mellitus

Exclusion criteria

* Person with diabetes who were treated with oral hypoglycemic agent or insulin * Individuals with type 1 diabetes, gestational diabetes, active hepatitis/liver cirrhosis, chronic renal failure on hemodialysis, congestive heart failure, or other known major disease

Design outcomes

Primary

Measure	Time frame
serum METRNL concentration	on the 1 day of oral glucose tolerance test

Outcome results